miércoles, 12 de julio de 2023

Insights About the FDA/EMA Parallel Scientific Advice Program for Complex Generic/Hybrid Drug Products

https://www.fda.gov/drugs/cder-small-business-industry-assistance-sbia/insights-about-fdaema-parallel-scientific-advice-program-complex-generichybrid-drug-products?utm_medium=email&utm_source=govdelivery

No hay comentarios: